> top > docs > PubMed:25589620 > annotations

PubMed:25589620 JSONTXT

Annnotations TAB JSON ListView MergeView

PubTator4TogoVar

Id Subject Object Predicate Lexical cue proteinmutation
25589620_0 1202-1211 ProteinMutation denotes Ile105Val rs1695
25589620_1 1542-1547 ProteinMutation denotes H472Q rs1870377

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T6 812-958 Sentence denotes EXPERIMENTAL DESIGN: DNA from 746 stage II/III rectal patients enrolled in the Southwest Oncology Group (SWOG) S9304 phase III trial was analyzed.
T1 0-43 Sentence denotes Pharmacogenetic Analysis of INT 0144 Trial:
T2 44-158 Sentence denotes Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
T3 159-167 Sentence denotes PURPOSE:
T4 168-579 Sentence denotes We tested whether 18 polymorphisms in 16 genes (GSTP1, COX2, IL10, EGFR, EGF, FGFR4, CCDN1, VEGFR2, VEGF, CXCR2, IL8, MMP3, ICAM1, ERCC1, RAD51, and XRCC3) would predict disease-free survival (DFS), overall survival (OS), and toxicity in the INT0144 trial, which was designed to investigate different postoperative regimens of 5-fluorouracil (5-FU)-based chemoradiation (CRT) in locally advanced rectal cancers:
T5 580-811 Sentence denotes Arm 1 consisted of bolus 5-FU followed by 5-FU protracted venous infusion (PVI) with radiotherapy; arm 2 was induction and concomitant PVI 5-FU with radiotherapy and arm 3 was induction and concomitant bolus 5-FU with radiotherapy.
T7 959-1044 Sentence denotes Genomic DNA was extracted from formalin-fixed, paraffin-embedded (FFPE) tumor tissue.
T8 1045-1186 Sentence denotes The polymorphisms were analyzed using direct DNA-sequencing or polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
T9 1187-1311 Sentence denotes RESULTS: GSTP1-Ile105Val (rs1695) was significantly associated with DFS and OS and its effect did not vary by treatment arm.
T10 1312-1432 Sentence denotes The five-year DFS and OS were 53% and 58%, respectively, for G/G, 66% and 72% for G/A, and 57% and 66% for A/A patients.
T11 1433-1530 Sentence denotes In arm 2, IL8-251A/A genotype (rs4073) was associated with a lower risk of toxicities (P = 0.04).
T12 1531-1696 Sentence denotes The VEGFR2 H472Q Q/Q genotype (rs1870377) was associated with a higher risk of grade 3-5 proximal upper gastrointestinal tract (PUGIT) mucositis (P = 0.04) in arm 2.
T13 1697-1794 Sentence denotes However, in arm 1, this genotype was associated with a lower risk of PUGIT mucositis (P = 0.004).
T14 1795-1992 Sentence denotes CONCLUSION: rs1695 may be prognostic in patients with rectal cancer treated with adjuvant CRT. rs4073 and rs1870377 may exhibit different associations with toxicity, according to the 5-FU schedule.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10429 91-99 DiseaseOrPhenotypicFeature denotes Toxicity MESH:D064420
10430 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer MESH:D012004
10431 117-125 OrganismTaxon denotes Patients NCBITaxon:9606
10432 139-143 ChemicalEntity denotes 5-FU MESH:D005472
10433 216-221 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
10434 223-227 GeneOrGeneProduct denotes COX2 NCBIGene:4513
10435 229-233 GeneOrGeneProduct denotes IL10 NCBIGene:3586
10436 235-239 GeneOrGeneProduct denotes EGFR NCBIGene:1956
10437 241-244 GeneOrGeneProduct denotes EGF NCBIGene:1950
10438 246-251 GeneOrGeneProduct denotes FGFR4 NCBIGene:2264
10439 253-258 GeneOrGeneProduct denotes CCDN1 NCBIGene:595
10440 260-266 GeneOrGeneProduct denotes VEGFR2 NCBIGene:3791
10441 268-272 GeneOrGeneProduct denotes VEGF NCBIGene:7422
10442 274-279 GeneOrGeneProduct denotes CXCR2 NCBIGene:3579
10443 281-284 GeneOrGeneProduct denotes IL8 NCBIGene:3576
10444 286-290 GeneOrGeneProduct denotes MMP3 NCBIGene:4314
10445 292-297 GeneOrGeneProduct denotes ICAM1 NCBIGene:3383
10446 299-304 GeneOrGeneProduct denotes ERCC1 NCBIGene:2067
10447 306-311 GeneOrGeneProduct denotes RAD51 NCBIGene:5888
10448 317-322 GeneOrGeneProduct denotes XRCC3 NCBIGene:7517
10449 394-402 DiseaseOrPhenotypicFeature denotes toxicity MESH:D064420
10450 495-509 ChemicalEntity denotes 5-fluorouracil MESH:D005472
10451 511-515 ChemicalEntity denotes 5-FU MESH:D005472
10452 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers MESH:D012004
10453 605-609 ChemicalEntity denotes 5-FU MESH:D005472
10454 622-626 ChemicalEntity denotes 5-FU MESH:D005472
10455 719-723 ChemicalEntity denotes 5-FU MESH:D005472
10456 788-792 ChemicalEntity denotes 5-FU MESH:D005472
10457 866-874 OrganismTaxon denotes patients NCBITaxon:9606
10458 990-998 ChemicalEntity denotes formalin MESH:D005557
10459 1006-1014 ChemicalEntity denotes paraffin MESH:D010232
10460 1031-1036 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10461 1196-1201 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
10462 1202-1211 SequenceVariant denotes Ile105Val DBSNP:rs1695
10463 1213-1219 SequenceVariant denotes rs1695 DBSNP:rs1695
10464 1423-1431 OrganismTaxon denotes patients NCBITaxon:9606
10465 1443-1446 GeneOrGeneProduct denotes IL8 NCBIGene:3576
10466 1446-1453 SequenceVariant denotes -251A/A DBSNP:rs4073
10467 1464-1470 SequenceVariant denotes rs4073 DBSNP:rs4073
10468 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities MESH:D064420
10469 1535-1541 GeneOrGeneProduct denotes VEGFR2 NCBIGene:3791
10470 1542-1547 SequenceVariant denotes H472Q DBSNP:rs1870377
10471 1562-1571 SequenceVariant denotes rs1870377 DBSNP:rs1870377
10472 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis MESH:D052016
10473 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis MESH:D052016
10474 1807-1813 SequenceVariant denotes rs1695 DBSNP:rs1695
10475 1835-1843 OrganismTaxon denotes patients NCBITaxon:9606
10476 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer MESH:D012004
10477 1890-1896 SequenceVariant denotes rs4073 DBSNP:rs4073
10478 1901-1910 SequenceVariant denotes rs1870377 DBSNP:rs1870377
10479 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity MESH:D064420
10480 1978-1982 ChemicalEntity denotes 5-FU MESH:D005472

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer 0006519
T2 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers 0006519
T3 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis 0020579
T4 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis 0020579
T5 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer 0006519
T6 1856-1862 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1202-1211 SequenceVariant denotes Ile105Val
T2 1213-1219 SequenceVariant denotes rs1695
T3 1446-1451 SequenceVariant denotes -251A
T4 1464-1470 SequenceVariant denotes rs4073
T5 1542-1547 SequenceVariant denotes H472Q
T6 1562-1571 SequenceVariant denotes rs1870377
T7 1807-1813 SequenceVariant denotes rs1695
T8 1890-1896 SequenceVariant denotes rs4073
T9 1901-1910 SequenceVariant denotes rs1870377

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 216-221 GeneOrGeneProduct denotes GSTP1
T2 223-227 GeneOrGeneProduct denotes COX2
T3 229-233 GeneOrGeneProduct denotes IL10
T4 235-239 GeneOrGeneProduct denotes EGFR
T5 246-251 GeneOrGeneProduct denotes FGFR4
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T7 268-272 GeneOrGeneProduct denotes VEGF
T8 274-279 GeneOrGeneProduct denotes CXCR2
T9 281-284 GeneOrGeneProduct denotes IL8
T10 286-290 GeneOrGeneProduct denotes MMP3
T11 292-297 GeneOrGeneProduct denotes ICAM1
T12 299-304 GeneOrGeneProduct denotes ERCC1
T13 306-311 GeneOrGeneProduct denotes RAD51
T14 317-322 GeneOrGeneProduct denotes XRCC3
T15 580-585 GeneOrGeneProduct denotes Arm 1
T16 679-684 GeneOrGeneProduct denotes arm 2
T17 1108-1118 GeneOrGeneProduct denotes polymerase
T18 1119-1124 GeneOrGeneProduct denotes chain
T19 1196-1201 GeneOrGeneProduct denotes GSTP1
T20 1436-1441 GeneOrGeneProduct denotes arm 2
T21 1443-1446 GeneOrGeneProduct denotes IL8
T22 1535-1541 GeneOrGeneProduct denotes VEGFR2
T23 1690-1695 GeneOrGeneProduct denotes arm 2
T24 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 28-31 GeneOrGeneProduct denotes INT
T2 171-177 GeneOrGeneProduct denotes tested
T3 203-208 GeneOrGeneProduct denotes in 16
T4 216-221 GeneOrGeneProduct denotes GSTP1
T5 223-227 GeneOrGeneProduct denotes COX2
T6 229-233 GeneOrGeneProduct denotes IL10
T7 235-239 GeneOrGeneProduct denotes EGFR
T8 246-251 GeneOrGeneProduct denotes FGFR4
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 268-272 GeneOrGeneProduct denotes VEGF
T11 274-279 GeneOrGeneProduct denotes CXCR2
T12 281-284 GeneOrGeneProduct denotes IL8
T13 286-290 GeneOrGeneProduct denotes MMP3
T14 292-297 GeneOrGeneProduct denotes ICAM1
T15 299-304 GeneOrGeneProduct denotes ERCC1
T16 306-311 GeneOrGeneProduct denotes RAD51
T17 317-322 GeneOrGeneProduct denotes XRCC3
T18 330-345 GeneOrGeneProduct denotes predict disease
T19 517-522 GeneOrGeneProduct denotes based
T20 580-585 GeneOrGeneProduct denotes Arm 1
T21 679-684 GeneOrGeneProduct denotes arm 2
T22 852-854 GeneOrGeneProduct denotes II
T23 855-858 GeneOrGeneProduct denotes III
T24 935-938 GeneOrGeneProduct denotes III
T25 1031-1036 GeneOrGeneProduct denotes tumor
T26 1108-1118 GeneOrGeneProduct denotes polymerase
T27 1119-1124 GeneOrGeneProduct denotes chain
T28 1180-1184 GeneOrGeneProduct denotes RFLP
T29 1196-1201 GeneOrGeneProduct denotes GSTP1
T30 1289-1293 GeneOrGeneProduct denotes vary
T31 1321-1325 GeneOrGeneProduct denotes year
T32 1386-1393 GeneOrGeneProduct denotes 72% for
T33 1411-1418 GeneOrGeneProduct denotes 66% for
T34 1436-1441 GeneOrGeneProduct denotes arm 2
T35 1443-1446 GeneOrGeneProduct denotes IL8
T36 1535-1541 GeneOrGeneProduct denotes VEGFR2
T37 1690-1695 GeneOrGeneProduct denotes arm 2
T38 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 338-345 DiseaseOrPhenotypicFeature denotes disease D004194
T4 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T5 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T6 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T8 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T10 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 216-221 GeneOrGeneProduct denotes GSTP1
T2 223-227 GeneOrGeneProduct denotes COX2
T3 229-233 GeneOrGeneProduct denotes IL10
T4 235-239 GeneOrGeneProduct denotes EGFR
T5 246-251 GeneOrGeneProduct denotes FGFR4
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T7 268-272 GeneOrGeneProduct denotes VEGF
T8 274-279 GeneOrGeneProduct denotes CXCR2
T9 281-284 GeneOrGeneProduct denotes IL8
T10 286-290 GeneOrGeneProduct denotes MMP3
T11 292-297 GeneOrGeneProduct denotes ICAM1
T12 299-304 GeneOrGeneProduct denotes ERCC1
T13 306-311 GeneOrGeneProduct denotes RAD51
T14 317-322 GeneOrGeneProduct denotes XRCC3
T15 580-585 GeneOrGeneProduct denotes Arm 1
T16 1196-1201 GeneOrGeneProduct denotes GSTP1
T17 1443-1446 GeneOrGeneProduct denotes IL8
T18 1535-1541 GeneOrGeneProduct denotes VEGFR2
T19 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 1031-1036 DiseaseOrPhenotypicFeature denotes tumor 0005070
T2 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis 0020579|0000888
T4 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis 0020579|0000888
T6 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer 0044937|0006519

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 338-345 DiseaseOrPhenotypicFeature denotes disease D004194
T4 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T5 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T6 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T8 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T10 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T11 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T4 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T5 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T6 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T7 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T8 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T10 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 139-143 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T3 241-244 ChemicalEntity denotes EGF http://purl.obolibrary.org/obo/CHEBI_140739
T4 281-284 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T5 495-509 ChemicalEntity denotes 5-fluorouracil D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T7 511-515 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T9 605-609 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T11 622-626 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T13 719-723 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T15 788-792 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T17 990-998 ChemicalEntity denotes formalin D005557
T18 1006-1014 ChemicalEntity denotes paraffin D010232|ChemicalEntity
T20 1443-1446 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T21 1978-1982 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 866-874 OrganismTaxon denotes patients
T2 1423-1431 OrganismTaxon denotes patients
T3 1835-1843 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T21 1978-1982 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T20 1443-1446 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T18 1006-1014 ChemicalEntity denotes paraffin ChemicalEntity|D010232
T17 990-998 ChemicalEntity denotes formalin D005557
T15 788-792 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T13 719-723 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T11 622-626 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T9 605-609 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T7 511-515 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T5 495-509 ChemicalEntity denotes 5-fluorouracil http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T4 281-284 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T3 241-244 ChemicalEntity denotes EGF http://purl.obolibrary.org/obo/CHEBI_140739
T1 139-143 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T19 1709-1714 GeneOrGeneProduct denotes arm 1
T44313 1535-1541 GeneOrGeneProduct denotes VEGFR2
T9341 1443-1446 GeneOrGeneProduct denotes IL8
T16 1196-1201 GeneOrGeneProduct denotes GSTP1
T11011 580-585 GeneOrGeneProduct denotes Arm 1
T14 317-322 GeneOrGeneProduct denotes XRCC3
T37430 306-311 GeneOrGeneProduct denotes RAD51
T12 299-304 GeneOrGeneProduct denotes ERCC1
T93406 292-297 GeneOrGeneProduct denotes ICAM1
T10 286-290 GeneOrGeneProduct denotes MMP3
T17644 281-284 GeneOrGeneProduct denotes IL8
T8 274-279 GeneOrGeneProduct denotes CXCR2
T8234 268-272 GeneOrGeneProduct denotes VEGF
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T80266 246-251 GeneOrGeneProduct denotes FGFR4
T61221 235-239 GeneOrGeneProduct denotes EGFR
T66909 229-233 GeneOrGeneProduct denotes IL10
T2 223-227 GeneOrGeneProduct denotes COX2
T92556 216-221 GeneOrGeneProduct denotes GSTP1
T93010 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T10698 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T46952 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T90258 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T14663 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T45062 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T90570 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T52800 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T37712 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T84313 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T79210 1835-1843 OrganismTaxon denotes patients
T32207 1423-1431 OrganismTaxon denotes patients
T81674 866-874 OrganismTaxon denotes patients
T11383 1901-1910 SequenceVariant denotes rs1870377
T47744 1890-1896 SequenceVariant denotes rs4073
T63948 1807-1813 SequenceVariant denotes rs1695
T7172 1562-1571 SequenceVariant denotes rs1870377
T47503 1542-1547 SequenceVariant denotes H472Q
T69073 1464-1470 SequenceVariant denotes rs4073
T50845 1446-1451 SequenceVariant denotes -251A
T76587 1213-1219 SequenceVariant denotes rs1695
T87977 1202-1211 SequenceVariant denotes Ile105Val

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 571-578 HP_0002664 denotes cancers

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
25589620-10#94#103#geners1870377 1901-1910 geners1870377 denotes rs1870377
25589620-10#0#6#geners1695 1807-1813 geners1695 denotes rs1695
25589620-10#78#81#diseaseC1559154 1885-1888 diseaseC1559154 denotes CRT
25589620-10#42#55#diseaseC0007113 1849-1862 diseaseC0007113 denotes rectal cancer
25589620-10#78#81#diseaseC1559154 1885-1888 diseaseC1559154 denotes CRT
25589620-8#31#40#geners1870377 1562-1571 geners1870377 denotes rs1870377
25589620-8#11#16#geners1870377 1542-1547 geners1870377 denotes H472Q
25589620-8#135#144#diseaseC0521585 1666-1675 diseaseC0521585 denotes mucositis
94#103#geners187037778#81#diseaseC1559154 25589620-10#94#103#geners1870377 25589620-10#78#81#diseaseC1559154 associated_with rs1870377,CRT
94#103#geners187037742#55#diseaseC0007113 25589620-10#94#103#geners1870377 25589620-10#42#55#diseaseC0007113 associated_with rs1870377,rectal cancer
94#103#geners187037778#81#diseaseC1559154 25589620-10#94#103#geners1870377 25589620-10#78#81#diseaseC1559154 associated_with rs1870377,CRT
0#6#geners169578#81#diseaseC1559154 25589620-10#0#6#geners1695 25589620-10#78#81#diseaseC1559154 associated_with rs1695,CRT
0#6#geners169542#55#diseaseC0007113 25589620-10#0#6#geners1695 25589620-10#42#55#diseaseC0007113 associated_with rs1695,rectal cancer
0#6#geners169578#81#diseaseC1559154 25589620-10#0#6#geners1695 25589620-10#78#81#diseaseC1559154 associated_with rs1695,CRT
31#40#geners1870377135#144#diseaseC0521585 25589620-8#31#40#geners1870377 25589620-8#135#144#diseaseC0521585 associated_with rs1870377,mucositis
11#16#geners1870377135#144#diseaseC0521585 25589620-8#11#16#geners1870377 25589620-8#135#144#diseaseC0521585 associated_with H472Q,mucositis

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
25589620-0#28#31#gene27152 28-31 gene27152 denotes INT
25589620-0#103#116#diseaseC0007113 103-116 diseaseC0007113 denotes Rectal Cancer
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#149#154#gene7517 317-322 gene7517 denotes XRCC3
25589620-1#355#369#diseaseC1559154 523-537 diseaseC1559154 denotes chemoradiation
25589620-1#371#374#diseaseC1559154 539-542 diseaseC1559154 denotes CRT
25589620-1#396#410#diseaseC0007113 564-578 diseaseC0007113 denotes rectal cancers
25589620-1#355#369#diseaseC1559154 523-537 diseaseC1559154 denotes chemoradiation
25589620-1#371#374#diseaseC1559154 539-542 diseaseC1559154 denotes CRT
25589620-1#396#410#diseaseC0007113 564-578 diseaseC0007113 denotes rectal cancers
25589620-8#4#10#gene3791 1535-1541 gene3791 denotes VEGFR2
25589620-8#135#144#diseaseC0521585 1666-1675 diseaseC0521585 denotes mucositis
28#31#gene27152103#116#diseaseC0007113 25589620-0#28#31#gene27152 25589620-0#103#116#diseaseC0007113 associated_with INT,Rectal Cancer
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
149#154#gene7517355#369#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#355#369#diseaseC1559154 associated_with XRCC3,chemoradiation
149#154#gene7517371#374#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#371#374#diseaseC1559154 associated_with XRCC3,CRT
149#154#gene7517396#410#diseaseC0007113 25589620-1#149#154#gene7517 25589620-1#396#410#diseaseC0007113 associated_with XRCC3,rectal cancers
149#154#gene7517355#369#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#355#369#diseaseC1559154 associated_with XRCC3,chemoradiation
149#154#gene7517371#374#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#371#374#diseaseC1559154 associated_with XRCC3,CRT
149#154#gene7517396#410#diseaseC0007113 25589620-1#149#154#gene7517 25589620-1#396#410#diseaseC0007113 associated_with XRCC3,rectal cancers
4#10#gene3791135#144#diseaseC0521585 25589620-8#4#10#gene3791 25589620-8#135#144#diseaseC0521585 associated_with VEGFR2,mucositis